Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. BOERSE MUENCHEN
  5. Xlife Sciences AG
  6. News
  7. Summary
    XLS   CH0461929603

XLIFE SCIENCES AG

(XLS)
  Report
Real-time Quote. Real-time BOERSE MUENCHEN - 06/14 03:43:00 am
56.5 EUR   +3.67%
06/11DGAP-DD  : Xlife Sciences AG english
DJ
06/10XLIFE SCIENCES  : Unit Develops New Active Substance For COVID-19, Flu Therapies
MT
06/10XLIFE SCIENCES AG : Breakthrough in Drug Development
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

PRESS RELEASE : Xlife Sciences AG: Portfolio project listed on the Stock Exchange

05/14/2021 | 09:42am EDT
DGAP-News: Xlife Sciences AG / Key word(s): IPO 
Xlife Sciences AG: Portfolio project listed on the Stock Exchange 
2021-05-14 / 15:41 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
PRESS RELEASE 
Xlife Sciences AG (XLS): Portfolio project listed on the Stock Exchange 
Vitruvia Medical AG is listed on the Munich Stock Exchange since yesterday 
The shares of Vitruvia Medical AG are open for trading since yesterday on the Stock exchange in Munich. Vitruvia is 
based in Germany and Switzerland and develops circulatory systems for highly complex medical devices as a project 
portfolio of Xlife Sciences AG (XLS). The initial offering price of the shares is at EUR 22.60, above expectations. 
Following the listing on the stock exchange, Vitruvia Medical Services reached another milestone in the successful 
development of the company. Munich is well recognized for the extensive network of academic research and the industry 
as a leading city of technology in Germany. With the listing of Vitruvia on the Munich Stock Exchange, Xlife Sciences 
AG achieved a significantly higher valuation of the company in the project portfolio. 
About Vitruvia Medical AG 
Vitruvia Medical AG is a leading European commercial group in the Circular Economy in the field of medicine. The focus 
is on innovative circulatory systems for highly complex medical products, especially for robot assisted surgery. This 
is complemented with the trade and repair of medical products, as well as consulting and qualification services, 
Vitruvia supports hospitals in the transformation of surgeries and the value creation of higher safety and maximal 
efficiency of resources. In this way, Vitruvia unites innovative and sustainable solutions for the development of 
medical technology, customer use and economic success. 
About Xlife Sciences AG 
Xlife Sciences AG is a Swiss company with focus on investing in promising technologies in the life science industry. 
Xlife Sciences AG is building the bridge from research and development to healthcare markets by supporting researchers 
and entrepreneurs in positioning, structuring, developing and implementing their concepts. Together with industrial 
partners or universities, Xlife Sciences AG leads projects through the proof-of-concept phase after an invention 
disclosure or start-up. Subsequently, the firm focuses on out-licensing or selling the company, often with a 
combination of a strategic partnership. Xlife Sciences AG offers its investors direct access to the further development 
of innovative and future-oriented technologies at a very early stage. For more information, please visit: 
www.xlifesciences.ch 
For media inquiries: 
Oliver R. Baumann, CEO Xlife Sciences AG, Tel. +41 44 385 84 60, oliver.baumann@xlifesciences.ch 
=---------------------------------------------------------------------------------------------------------------------- 
2021-05-14 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Xlife Sciences AG 
              Klausstrasse 19 
              8008 Zürich 
              Switzerland 
Phone:        0041 44 385 84 60 
E-mail:       info@xlifesciences.ch 
Internet:     www.xlifesciences.ch 
ISIN:         CH0461929603 
WKN:          A2PK6Z 
Listed:       Regulated Unofficial Market in Frankfurt, Munich 
EQS News ID:  1196888 
 
End of News   DGAP News Service 
=------------ 

1196888 2021-05-14

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1196888&application_name=news 
 

(END) Dow Jones Newswires

May 14, 2021 09:41 ET (13:41 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL 0.04% 34479.6 Delayed Quote.12.61%
XLIFE SCIENCES AG 3.67% 56.5 Real-time Quote.0.00%
All news about XLIFE SCIENCES AG
06/11DGAP-DD  : Xlife Sciences AG english
DJ
06/10XLIFE SCIENCES  : Unit Develops New Active Substance For COVID-19, Flu Therapies
MT
06/10XLIFE SCIENCES AG : Breakthrough in Drug Development
EQ
06/03DGAP-DD  : Xlife Sciences AG english
DJ
05/20DGAP-DD  : Xlife Sciences AG english
DJ
05/14XLIFE SCIENCES  : Portfolio Project Vitruvia Medical Starts Trading in Germany
MT
05/14PRESS RELEASE  : Xlife Sciences AG: Portfolio project listed on the Stock Exchan..
DJ
05/14XLIFE SCIENCES AG : Portfolio project listed on the Stock Exchange
EQ
05/07XLIFE SCIENCES AG  : Notification and public disclosure of transactions by perso..
EQ
04/07DGAP-DD  : Xlife Sciences AG english
DJ
More news
Financials
Sales 2020 28,0 M 31,1 M 31,1 M
Net income 2020 25,1 M 27,9 M 27,9 M
Net Debt 2020 54,5 M 60,6 M 60,6 M
P/E ratio 2020 -
Yield 2020 -
Capitalization 221 M 246 M 246 M
EV / Sales 2020 9,83x
EV / Sales 2021 4,43x
Nbr of Employees -
Free-Float 100%
Chart XLIFE SCIENCES AG
Duration : Period :
Xlife Sciences AG Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price
Last Close Price 54,00 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
Sector and Competitors
1st jan.Capitalization (M$)
XLIFE SCIENCES AG0.00%246
MODERNA, INC.109.49%87 874
LONZA GROUP AG16.32%54 656
IQVIA HOLDINGS INC.35.87%46 658
CELLTRION, INC.-26.04%32 458
SEAGEN INC.-10.60%28 416